Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive

European Heart Journal
|November 1, 1983
PubMed

Insights

Two-dimensional echocardiography reveals diverse patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy, often missed by M-mode alone. Certain patterns, especially Type IV, are only detectable with 2D imaging, aiding accurate diagnosis.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy.
  • M-mode echocardiography has limitations in fully assessing the extent and pattern of hypertrophy in HCM.
  • Two-dimensional echocardiography offers a wider view of myocardial morphology.

Purpose of the Study:

  • To identify and classify diverse patterns of left ventricular hypertrophy in HCM using wide-angle 2D echocardiography.
  • To compare the diagnostic capabilities of 2D echocardiography versus M-mode echocardiography in HCM.
  • To correlate hypertrophy patterns with clinical manifestations and functional limitations.

Main Methods:

  • Utilized wide-angle two-dimensional echocardiography to assess left ventricular hypertrophy patterns in HCM patients.
  • Classified hypertrophy into four basic distribution patterns (Types I-IV).
  • Correlated echocardiographic findings with M-mode assessments, electrocardiogram patterns, and clinical data.

Main Results:

  • Identified four distinct patterns of left ventricular hypertrophy distribution in HCM.
  • Type III (septum and anterolateral free wall) was most frequent (52%).
  • Type IV hypertrophy patterns were often inaccessible to M-mode, requiring 2D echocardiography for diagnosis. Marked hypertrophy (Type III) correlated with functional limitation and subaortic obstruction.

Conclusions:

  • Wide-angle 2D echocardiography is superior to M-mode for detecting diverse and extensive patterns of left ventricular hypertrophy in HCM.
  • Specific hypertrophy patterns, particularly Type IV, necessitate 2D echocardiography for diagnosis.
  • The distribution pattern of hypertrophy influences functional limitation and the presence of subaortic obstruction.

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...